CXCL12 and gestational diabetes: The research group of Dr. Mojgan Karimabad found increased serum levels of CXCL1 and CXCL12, chemokines with pro-angiogenic properties [246,247,248], in neonates from GDM mothers, whereas antiangiogenic chemokines CXCL9 and CXCL10 were downregulated, compared to neonates from healthy mothers without GDM [249].